Introduction {#s1}
============

Diabetic nephropathy (DN) is a major health epidemic and is the main cause of morbidity and mortality in diabetes. It is the single most common cause of end-stage renal failure [@pone.0044714-Dronavalli1], [@pone.0044714-BlazquezMedela1]. A very characteristic and initial event of the development of DN is glomerulosclerosis, which is featured by increased thickness of the glomerular basement membrane, and widening of the mesangium with accumulation of extracellular matrix (ECM). Furthermore, the degree of mesangial expansion is strongly related to the clinical manifestations of diabetic nephropathy, such as albuminuria and decreased glomerular filtration rate [@pone.0044714-Mauer1], [@pone.0044714-Drummond1]. Even though inherent susceptibility seems to influence the rate at which glomerular injury develops, hyperglycemia seems to be the primary driving force for cellular damage [@pone.0044714-Balakumar1]. In this regard, intensive control of glycemia in type I diabetic patients was associated with a significant reduction in the development and progression of nephropathy [@pone.0044714-1].

Although, the underlying biochemical and cellular mechanisms that promote renal injury in diabetes are still undefined, accumulating evidence supports a relationship between the activity of the kallikrein-kinin system (KKS) and renal impairment. It has been shown that type I diabetic patients with hyperfiltration as well as diabetic rats with increased glomerular filtration rate (GFR) and renal plasma flow (RPF) are associated with increased active kallikrein excretion rate [@pone.0044714-Harvey1], [@pone.0044714-Harvey2]. In addition, treatment of hyperfiltering diabetic rats with aprotinin, a kallikrein inhibitor, or with a B~2~-kinin receptor (B~2~R) antagonist, increases the renal vascular resistance and reduces GFR and RPF [@pone.0044714-Jaffa1]. Furthermore, previous findings from our lab have shown that increased plasma prekallikrein activity is associated with increased albumin excretion rate; these data have been demonstrated in DCCT/EDIC-cohort of type 1 diabetic patients [@pone.0044714-Jaffa2].

While most of the physiological actions of the KKS are attributed to the generation of BK and activation of B~2~R, the intracellular signaling pathways initiated upon activation of B~2~R leading to expression of prosclerotic factors that ultimately result in glomerular injury are just beginning to be defined. Activation of B~2~R by BK results in marked induction of connective tissue growth factor (CTGF), collagen I and transforming growth factor-β type II receptor (TGF-ßRII) in mesangial cells. Inhibition of B~2~R by Icatibant significantly reduced the increase in collagen I and CTGF mRNA levels in response to BK challenge [@pone.0044714-Tan1]. Of interest, it has been shown that the glomerular expression of B~2~Rs are increased in diabetes and a targeted deletion B~2~R protects against the development of DN [@pone.0044714-Christopher1], [@pone.0044714-Tan2]. Furthermore, diabetic B~2~R^−/−^ null mice display reduced albumin excretion rate (AER), as well as reduced glomerular and tubular injury compared to diabetic B~2~R^+/+^ mice [@pone.0044714-Tan2].

In this study, we employed a global microarray analysis coupled with systems biology study to investigate the differential gene expression in wild type control (B~2~R^+/+^) and diabetic (B~2~R^+/+^D) mice as well as in B~2~R knockout-control (B~2~R^−/−^) mice and in B~2~R knockout-diabetic (B~2~R^−/−^D) mice in order to identify candidate genes that may be involved in the development of diabetic nephropathy. The objective of our study was to determine 1) whether deletion of B~2-~receptors will result in alteration in specific gene expression profiles whose specific functions can shed light on the role(s) of B~2-~receptors, and 2) whether diabetes will result in differences in the patterns of gene expression and pathways between B~2~R^+/+^D and B~2~R^−/−^D mice that can be linked to the pathological manifestation observed after the induction of DN.

Methods {#s2}
=======

Study Design {#s2a}
------------

To address the contribution of B~2~R to the development of diabetic nephropathy, we studied B~2~R knockout mice (B~2~R^−/−^) and their wild type littermates (B~2~R^+/+^). Male B~2~R^−/−^ mice (strain \# B6 129S-BdKrb2, Jackson Laboratories, Bar Harbor, ME) and B~2~R^+/+^ mice (strain \# B6 129 SF2/J, Jackson Laboratories, Bar Harbor, ME) weighing 20--30 g were used in our studies. Mice were housed three per cage in a light and temperature controlled room and had free access to food and water. Diabetes was induced by daily intraperitoneal injection of streptozotocin (50mg/kg body weight) for 3--5 days. Diabetes was confirmed in STZ-treated mice by tail vein plasma glucose levels. We used a total of 12 mice for this study divided into 4 groups, 3 mice in each group. Group 1, wild type non-diabetic-controls (B~2~R^+/+^C); group 2, wild type-diabetic (B~2~R^+/+^ D); group 3, B~2~R knockout-control (B~2~R^−/−^C) and group 4, B~2~R knockout-diabetic (B~2~R^−/−^D). Glucose levels and body weights were measured at predetermined intervals to characterize the diabetic state and to ensure adequate metabolic control. Every week mice were placed in metabolic cages (Nalgene) for 24 h to acclimate, and then 24h urine collections were obtained from all mice to measure albumin excretion rate. The mice were sacrificed 6 months after the induction of diabetes. The studies were done in line with the Guide for the Care and Use of laboratory Animals published by the National Institutes of Health (NIH Publication No 85--23, revised 1996). The study was approved by the Institutional Animal Care and Use Committee at the Medical University of South Carolina.

![Plasma glucose levels (A) and body weights (B) in diabetic (B~2~R^+/+^D and B~2~R^−/−^D) and control (B~2~R^+/+^C and B~2~R^−/−^C) mice.\
(**A**) Plasma glucose levels were significantly increased two weeks after STZ injection in both diabetic groups (B~2~R^+/+^D and B~2~R^−/−^D) compared to B~2~R^+/+^C and B~2~R^−/−^C (P\<0.001) and remained significantly elevated for the duration of the study. (**B**) Initial body weights were not significantly different between diabetic and control mice. However, B~2~R^−/−^D mice had significantly reduced bodyweight after 14 weeks and B~2~R^+/+^D after 20 weeks compared with B~2~R^+/+^ C and B~2~R^−/−^ C mice and this reduction in body weight was maintained for the duration of the study (P\<0.001 vs. B~2~R^+/+^C and B~2~R^−/−^C).](pone.0044714.g001){#pone-0044714-g001}

RNA Extraction {#s2b}
--------------

Kidneys from control and diabetic mice (B~2~R^+/+^C, B~2~R^+/+^D, B~2~R^−/−^C and B~2~R^−/−^D mice, n = 3 per group) were removed under anesthesia and cortexes were cut off to extract RNA. For RNA extraction and purification, a method combined Trizol (Cat. No.15596-018, Invitrogen Life Technologies) and RNeasy Midi Kit (Cat. No.75144, QIAGEN) for total RNA isolation from animal tissue was used. Briefly, the cortexes were homogenized using an appropriate volume of Trizol (1ml of Trizol/100 mg tissue). Then chloroform (0.2 ml/1 ml Trizol used) was added to separate the aqueous phase from protein phase. Total RNA was dissolved in the aqueous phase. RNA purification followed the protocol of RNeasy kit handbook. The RNA concentration was determined in a spectrophotometer (ultraspec III, Pharmacia) by absorbance at 260 nm. The ratio of A260 to A280 was calculated to check the purification of RNA, and the rRNA ratio of 28S/18S using 2100 Bioanalyzer (Aglilent) was measured to check the quality of RNA.

![Albumin excretion rate (AER) in diabetic (B~2~R^+/+^D and B~2~R^−/−^D) and control (B~2~R^+/+^C and B~2~R^−/−^C) mice.\
AER was significantly higher in B~2~R^+/+^D mice compared to B~2~R^−/−^ D (†P\<0.05) and to B~2~R^+/+^C and or B~2~R^−/−^C (\*P\<0.001), as early as two weeks after induction of diabetes and remained elevated for the duration of the study period.](pone.0044714.g002){#pone-0044714-g002}

Synthesis of Double-stranded cDNA from Total RNA {#s2c}
------------------------------------------------

Total RNA (10 µg) from each sample was used to synthesize ds-cDNA. In primer hybridization, 10 µg of RNA, T7-(dT)~24~ primer (100 pmol/ul, HPLC purified) and DEPC-H~2~O were added to the tube and incubated at 70°C for 10 min. Next, 5× first strand cDNA buffer 4 µl, DTT (0.1 M) 2 µl dNTP (10 mM) were added to each tube, incubated at 42°C for 2 min. and followed by addition of SuperScrip II RT (200 U/µl) 2 µl and incubated at 42°C for 1 hour to synthesize the first strand of cDNA. The final volume for the first strand cDNA synthesis was 20 µl. In order to synthesis the second strand, the following reagents were added to the first strand synthesis tube: DEPC-treated water 91 µl, 5× second strand cDNA reaction buffer 30 µl, 10 mM dNTP mix 3 µl, 10 U/µl *E*.*coli* DNA ligase, 10 U/µl *E*.*coli* DNA polymerase I 4 µl and 2 U/µl *E*.*coli* RNase H. The final volume of the second strand reaction was 150 µl. The reaction tubes were incubated at 16°C for 2 hours in a cooling water bath. After the incubation, 2 µl of \[10 U\] T4 DNA polymerase was added to the reaction tube, incubated at 16°C for 5 min, followed by addition of 10 µl of 0.5 M EDTA to complete synthesis of the second cDNA strand.

![Hierarchical clustering of gene expression in the kidney among four groups of mice: B~2~R^+/+^C, B~2~R^+/+^D, B~2~R^−/−^C and B~2~R^−/−^D.\
Each column represents one sample, and the color bars represent the median value of three array experiments for an individual mouse for that gene.](pone.0044714.g003){#pone-0044714-g003}

Synthesis of Biotin-labeled cRNA {#s2d}
--------------------------------

Before Synthesis of biotin-labeled cRNA, double-strand cDNA was cleaned according to the GeneChip Sample Cleanup Module. The following reagents were used in the final reaction volume (40 µl): 4 µl of 10×HY reaction buffer, 4 µl of 10×Biotin-labeled ribonucleotides, 4 µl of 10×DTT, 4 µl 10×RNase inhibitor mix, 2 µl 20×T7 RNA polymerase and distilled water. All of the reagents were mixed and incubated at 37°C for 5 hours, with gentle mixing of the tube every 30 min. The biotin-labeled cRNA was cleaned according to the GeneChip Sample Cleanup Module before quantification.

![Biological processes depicting genes that are altered in response to B~2~R disruption are shown in pie chart.\
Data compares genes altered in B~2~R^−/−^C vs. B~2~R^+/+^C (**A**) upregulated genes and (**B**) downregulated genes.](pone.0044714.g004){#pone-0044714-g004}

10.1371/journal.pone.0044714.t001

###### Upregulated and Downregulated Genes in B~2~R^−/−^C vs. B~2~R^+/+^C.

![](pone.0044714.t001){#pone-0044714-t001-1}

  Accession ID                               Gene                              Gene ID   Fold Change   P value
  -------------- ------------------------------------------------------------ --------- ------------- ----------
  NM_018731       Atp4a ATPase, H+/K+ exchanging, gastric, alpha polypeptide    11944       2.77       0.001678
  AK007618                          Ak3 adenylate kinase 3                      56248       1.85       0.017419
  NM_001164745             Ptp4a2 protein tyrosine phosphatase 4a2              19244       2.97       0.028458
  NM_012032                     Serinc3 serine incorporator 3                   26943       2.14       0.013514
  NM_013467         Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1       11668       −4.13      0.003764
  BC027434                Hbb-b2 hemoglobin, beta adult minor chain             15130       −2.42      0.002817
  NM_008218                 Hba-a1 hemoglobin alpha, adult chain 1              15122       −2.54      0.00193
  NM_011921         Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7       26358       −2.35      0.005015
  BC005569                  Rnase4 ribonuclease, RNase A family 4               58809       −4.28      0.00286
  AF031467          Bcat2 branched chain aminotransferase 2, mitochondrial      12036       −2.49      0.047991
  NM_011844                       Mgll monoglyceride lipase                     23945       −3.01      0.028657
  BC027279         Blvrb biliverdin reductase B (flavin reductase (NADPH))     233016       −1.94      0.016502
  NM_001003953             Kdm2b lysine (K)-specific demethylase 2B             30841       −1.81      0.001347

cRNA Fragmentation and Microarray Procedure {#s2e}
-------------------------------------------

To reach a final concentration of 1 µg/µl, 20 µg cRNA and 8 µl of 5×fragmentation buffer were incubated at 94°C for 35 min. A total of 15 µl of each sample (1.0 µg/µl) was used for preparation of hybridization cocktail that was loaded onto the GeneChips (Mouse Expression Array 430 A, Affymetrix) and hybridized for 16 h at 45°C in the Affymetrix GeneChip hybridization oven 640. Following this, the chips were loaded into the Affymetrix GeneChip Fluidics Station 400 with double stain antibody amplification solution for washing and staining. Finally, the GeneChips were scanned using the Hewlett Packard GeneArray Scanner 2500.

Expression values were derived using RMA (for normalization and background subtraction) as executed by the software RMAexpress (University of California, Berkeley). Expressed genes were determined according to the following criterion: any gene for which a sample had an average detection p-value (MASS) \>0.04 (standard threshold for MASS "presence" call); all other genes were excluded from further consideration. RMA expression values were converted from log-base 2 and imported into dchip. Dchip was used to perform comparisons for all desired group comparisons. Criteria for comparison were: Fold change of 1.8; 90% confidence bound of fold change was used; T-test with p-value \<0.05; false discovery rate was calculated as the median number genes discovered in 50 iterations of permutated samples.

![Biological processes depicting genes that are altered in response to diabetes in wild type control mice are shown in pie chart.\
Data compares genes altered in B~2~R^+/+^D vs. B~2~R^+/+^C (**A**) upregulated genes and (**B**) downregulated genes.](pone.0044714.g005){#pone-0044714-g005}

10.1371/journal.pone.0044714.t002

###### Upregulated and Downregulated Genes in B~2~R^+/+^D vs. B~2~R^+/+^C.

![](pone.0044714.t002){#pone-0044714-t002-2}

  Accession ID                                          Gene                                          Gene ID   Fold Change   P value
  -------------- ----------------------------------------------------------------------------------- --------- ------------- ----------
  NM_019659              Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1            56379        2.1       0.005281
  NM_011819                            Gdf15 growth differentiation factor 15                          23886       1.82       0.031049
  AK007630                        Cdkn1a cyclin-dependent kinase inhibitor 1A (P21)                    12575       4.61       0.000166
  AK008108                                        Sulf2 sulfatase 2                                    72043       1.91       0.027765
  AK013376                        Aplp2 amyloid beta (A4) precursor-like protein 2                     11804       1.88       0.022803
  AK007618                                     Ak3 adenylate kinase 3                                  56248       1.99       0.010866
  NM_030558                                  Car15 carbonic anhydrase 15                               80733       1.99       0.013746
  AAC42082                                         Ccng1 cyclin G1                                     12450       1.91       0.007673
  NM_012032                                 Serinc3 serine incorporator 3                              26943       2.02       0.018166
  BC010197                                     Cpe carboxypeptidase E                                  12876       −2.91      0.001076
  NM_008321                                Id3 inhibitor of DNA binding 3                              15903       −1.97      0.007472
  NM_013475                                     Apoh apolipoprotein H                                  11818       −2.55      0.005274
  BC027434                            Hbb-b2 hemoglobin, beta adult minor chain                        15130       −2.17      0.003365
  NM_008218                            Hba-a1 hemoglobin alpha, adult chain 1                          15122       −2.1       0.001414
  D89669                   Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1              13081       −2.34      0.038907
  BC020534                                Cckar cholecystokinin A receptor                             12425       −2.28      0.032112
  NM_007812                 Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5               13087       −1.85      0.038301
  BC005569                              Rnase4 ribonuclease, RNase A family 4                          58809       −3.31      0.002108
  NM_030888                    C1qtnf3 C1q and tumor necrosis factor related protein 3                 81799       −2.24      0.025602
  BC013343                           Hpd 4-hydroxyphenylpyruvic acid dioxygenase                       15445       −1.98      0.027661
  S64539                             Odc1 ornithine decarboxylase, structural 1                        18263       −1.86      0.045764
  AK011116                             Hba-a1 hemoglobin alpha, adult chain 1                          15122       −1.98      0.004592
  AAH23851                     Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1                208715       −2.71      0.013067
  NM_001004148    Slc13a5 solute carrier family 13 (sodium-dependent citrate transporter), member 5   237831       −1.84      0.00636
  EDL41048                                 Id4 inhibitor of DNA binding 4                              15904       −1.95      0.031173

Real-Time PCR {#s2f}
-------------

Total RNA (2 µg) was converted to cDNA using MLV Reverse Transcriptase (Promega, Madison, WI) according to the manufacturer's protocol at 37°C for 1 hr. To determine the validity of primers and appropriate Tm for Real Time PCR, the primers were first amplified in a PCR reaction to ensure that only one band is amplified. The following primers were designed so that all of the PCR products are within 75--150 bp (Integrated DNA Technologies Inc). β-actin: 5′-actgccgctcctcttcctc-3′; 5′-ccgctcgttgccaatagtga-3′; Growth hormone receptor: 5′- ttctgggaagcctcgattcaccaa-3′, 5′:cagcttgtcgttggctttcccttt-3′; Insulin growth factor binding protein-1(IGFBP1) 5′: agatcgccgacctcaagaaatgga-3′, 5′-tgttgggctgcagctaatctctct-3′; IGFBP4: 5′-tcggaaatcgaagccatccaggaa-3′, 5′-tgaagctgttgttgggatgttcgc-3′; Extracellular superoxide distmutase (EC-SOD) 5′-tgcatgcaatctgcagggtacaac-3′, 5′-aagagaaccaagccggtgatctgt-3′; Flavin containing monooxygenase 2 (FMO2) 5′-caacgcactgtctttgacgctgtt-3′, 5′-atggaaatactggcttcggaacct-3′; Glutathione-S-transferase a-2 (GSTa-2) 5′-atgacaaggactaccttgtgggca-3′, 5′-ggctggcatcaagctcttcaacat-3′. For each target gene, a standard curve was established. This was achieved by performing a series of 3-fold dilutions of the gene of interest. Negative control was made using the same volume of Rnase-free water instead of sample. The master mix was prepared as follows: 2× SYBR Green Supermix (cat. No. 170--8880, BIO-RAD) 12.5 µl, forward and reverse primer 0.25 µl respectively and ddH2O 12 µl. For each well, 22 µl of master mix was loaded first, followed by 3 µl of sample, mixed well to get total reaction volume of 25 µl. For plate setup, SYBR-490 was chosen as fluorophore. The plate was covered with a sheet of optical sealing film. PCR conditions were 95°C for 3 min, followed by 40 cycles of 95°C for 10 sec, 58°C for 1 min for ß-actin and for all the other genes 60°C for 1 min, then 95°C for 1 min, 55°C for 1 min and 100 cycles of 55°C for 10 sec. All of the reactions were done in duplicate. The correlation coefficient is between 0.98-1, PCR efficiency is between 75--130%. The mRNA levels were expressed relative to ß-actin mRNA. Realtime PCR using iCycle™ iQ optical system software (version 3.0a) was used in our studies.

![Biological processes depicting genes that are altered in response to diabetes in B~2~R^−/−^ null mice are shown in pie chart.\
Data compares genes altered in B~2~R^−/−^D vs. B~2~R^−/−^C (**A**) upregulated genes and (**B**) downregulated genes.](pone.0044714.g006){#pone-0044714-g006}

10.1371/journal.pone.0044714.t003

###### Upregulated and Downregulated Genes in B~2~R^−/−^D vs. B~2~R^−/−^C.

![](pone.0044714.t003){#pone-0044714-t003-3}

  Accession ID                                                         Gene                                                        Gene ID   Fold Change   P value
  -------------- ---------------------------------------------------------------------------------------------------------------- --------- ------------- ----------
  BC009155                                         Mgst1 microsomal glutathione S-transferase 1                                     56615       1.97       0.035109
  NM_019703                                             Pfkp phosphofructokinase, platelet                                          56421       1.99       0.045538
  EDL25631                                               Mpzl2 myelin protein zero-like 2                                           14012       1.86       0.035095
  NM_019423                   Elovl2 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2                 54326       2.03       0.003224
  NM_013467                                   Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1                                 11668       8.21       0.015004
  NM_009994                                Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1                             13078       1.84       0.022511
  NM_009255                            Serpine2 serine (or cysteine) peptidase inhibitor, clade E, member 2                         20720       2.25       0.002624
  NM_021897                          Trp53inp1 transformation related protein 53 inducible nuclear protein 1                        60599       1.84       0.024129
  BC027434                                          Hbb-b2 hemoglobin, beta adult minor chain                                       15130       2.69       0.013965
  NM_025284                                                  Tmsb10 thymosin, beta 10                                               19240        1.9       0.024637
  NM_007631                                                      Ccnd1 cyclin D1                                                    12443       2.95       0.000665
  NM_007752                                                      Cp ceruloplasmin                                                   12870       2.49       0.007697
  NM_008218                                           Hba-a1 hemoglobin alpha, adult chain 1                                        15122        3.2       0.019897
  AF047838                                          Clca1 chloride channel calcium activated 1                                      12722       3.37       0.011734
  BC021776                                                  Apoc3 apolipoprotein C-III                                              11814       2.01       0.000641
  NM_009244                          Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B                        20701       2.24       0.006778
  NM_008332                             Ifit2 interferon-induced protein with tetratricopeptide repeats 2                           15958       2.05       0.022893
  NM_001198560                                     H2-Q7 histocompatibility 2, Q region locus 7                                     15018       1.84       0.013281
  NM_011921                                   Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7                                 26358       3.96       0.030189
  NM_013492                                                       Clu clusterin                                                     12759       1.92       0.000802
  NM_009705                                                   Arg2 arginase type II                                                 11847       1.98       0.00093
  D89669                                  Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1                            13081       3.09       0.079614
  NM_008341                                    Igfbp1 insulin-like growth factor binding protein 1                                  16006       2.81       0.042115
  NM_031161                                                    Cck cholecystokinin                                                  12424       2.17       0.002063
  NM_010281                                                Ggh gamma-glutamyl hydrolase                                             14590         2        0.012756
  NM_019738                                                  Nupr1 nuclear protein 1                                                56312       1.85       0.001812
  NM_008935                                                      Prom1 prominin 1                                                   19126       2.21       0.014173
  NM_031185                                     Akap12 A kinase (PRKA) anchor protein (gravin) 12                                   83397       1.86       0.00053
  NM_009831                                                      Ccng1 cyclin G1                                                    12450       2.15       0.007653
  NM_008182                                       Gsta2 glutathione S-transferase, alpha 2 (Yc2)                                    14858       2.65       0.000003
  NM_011313                                     S100a6 S100 calcium binding protein A6 (calcyclin)                                  20200       3.53       0.000785
  NM_011169                                                  Prlr prolactin receptor                                                19116       3.04       0.026061
  NM_010145                                           Ephx1 epoxide hydrolase 1, microsomal                                         13849       5.62       0.000013
  NM_013602                                                   Mt1 metallothionein 1                                                 17748       2.96       0.003938
  NM_009256                            Serpinb9 serine (or cysteine) peptidase inhibitor, clade B, member 9                         20723       1.88       0.031251
  NM_001166409                                           Rbm3 RNA binding motif protein 3                                           19652       2.57       0.034705
  NM_009162                                                    Scg5 secretogranin V                                                 20394       2.08       0.031656
  NM_013590                                                      Lyz1 lysozyme 1                                                    17110       2.11       0.004781
  BC010291                                      Ifitm3 interferon induced transmembrane protein 3                                   66141        2.1       0.001773
  AK007630                                      Cdkn1a cyclin-dependent kinase inhibitor 1A (P21)                                   12575       4.38       0.018945
  BC010747                                Cyp4a10 cytochrome P450, family 4, subfamily a, polypeptide 10                            13117       2.97       0.008145
  BC019601                                           Wsb1 WD repeat and SOCS box-containing 1                                       78889       2.08       0.017203
  AK011116                                            Hba-a1 hemoglobin alpha, adult chain 1                                        15122       2.87       0.004126
  NM_008630                                                   Mt2 metallothionein 2                                                 17750        2.3       0.000286
  AK002562                                              Reep6 receptor accessory protein 6                                          70335       1.83       0.006197
  AK019319                                                    Apoe apolipoprotein E                                                 11816       2.03       0.013394
  NM_009964                                                 Cryab crystallin, alpha B                                               12955       1.98       0.008461
  NM_009700                                                      Aqp4 aquaporin 4                                                   11829       2.24       0.04758
  NM_011403                                 Slc4a1 solute carrier family 4 (anion exchanger), member 1                              20533       1.88       0.005501
  NM_028071                                           Cotl1 coactosin-like 1 (Dictyostelium)                                        72042       2.52       0.045007
  NM_033521                                   Laptm4b lysosomal-associated protein transmembrane 4B                                114128       2.24       0.022123
  NM_017372                                                      Lyz2 lysozyme 2                                                    17105       3.11        0.0077
  NM_019989                                 Sh3bgrl SH3-binding domain glutamic acid-rich protein like                              56726        2.1       0.02642
  NM_001206367                                                     Gsn gelsolin                                                    227753       1.82       0.004725
  NM_001039392                                               Tmsb10 thymosin, beta 10                                               19240       2.41       0.009177
  NM_010169                                       F2r coagulation factor II (thrombin) receptor                                     14062       2.66       0.008048
  NM_007569                                    Btg1 B-cell translocation gene 1, anti-proliferative                                 12226        1.9       0.027652
  NM_013492                                                       Clu clusterin                                                     12759       3.04       0.023634
  NM_010664                                                      Krt18 keratin 18                                                   16668       2.33       0.032815
  NM_009242                                      Sparc secreted acidic cysteine rich glycoprotein                                   20692       2.77       0.01031
  NM_021281                                                      Ctss cathepsin S                                                   13040       1.94       0.003757
  NM_007631                                                      Ccnd1 cyclin D1                                                    12443       2.36       0.01662
  NM_011579                                               Tgtp1 T-cell specific GTPase 1                                            21822       2.11       0.048236
  NM_010501                             Ifit3 interferon-induced protein with tetratricopeptide repeats 3                           15959        2.4       0.043235
  NM_019975                                              Hacl1 2-hydroxyacyl-CoA lyase 1                                            56794       2.68       0.000059
  NM_012006                                               Acot1 acyl-CoA thioesterase 1                                             26897       2.11       0.001113
  NM_009735                                                  B2m beta-2 microglobulin                                               12010        2.8       0.025118
  NM_009517                                              Zmat3 zinc finger matrin type 3                                            22401       1.93       0.005952
  NM_054102                                       Ivns1abp influenza virus NS1A binding protein                                    117198       1.98       0.02154
  NM_009254                           Serpinb6a serine (or cysteine) peptidase inhibitor, clade B, member 6a                        20719       2.45       0.016523
  NM_011844                                                 Mgll monoglyceride lipase                                               23945        2.2       0.021782
  AF177041                                       Akr1c12 aldo-keto reductase family 1, member C12                                  622402       2.06       0.010183
  NM_016668                                        Bhmt betaine-homocysteine methyltransferase                                      12116       3.04       0.00654
  NM_010379                                  H2-Ab1 histocompatibility 2, class II antigen A, beta 1                                14961       1.86       0.01325
  NM_010169                                         coagulation factor II (thrombin) receptor                                       14062       2.02       0.003274
  AF263458                                                  Plac8 placenta-specific 8                                              231507       1.84       0.001426
  BC008184                                           Aldoc aldolase C, fructose-bisphosphate                                        11676         2        0.008866
  BC027340                                               Lyplal1 lysophospholipase-like 1                                          226791        1.8       0.001368
  BC012874                           Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B                        20701       2.34       0.024747
  NM_009735                                                  B2m beta-2 microglobulin                                               12010       1.88       0.015559
  AK011116                                            Hba-a1 hemoglobin alpha, adult chain 1                                        15122       2.52       0.003324
  NM_013492                                                       Clu clusterin                                                     12759       2.45       0.011136
  NM_001042611                                                   Cp ceruloplasmin                                                   12870       4.02       0.000586
  NM_010362                                          Gsto1 glutathione S-transferase omega 1                                        14873       2.53       0.001403
  NM_009369                                       Tgfbi transforming growth factor, beta induced                                    21810       1.82       0.021522
  NM_011701                                                        Vim vimentin                                                     22352       1.93       0.022829
  NM_008538                                Marcks myristoylated alanine rich protein kinase C substrate                             17118       1.83       0.018183
  NM_007620                                                 Cbr1 carbonyl reductase 1                                               12408       3.36       0.016972
  AF108501                                          Clca2 chloride channel calcium activated 2                                      80797       4.01       0.007099
  NM_013470                                                      Anxa3 annexin A3                                                   11745       1.81       0.022226
  NM_009156                                              Sepw1 selenoprotein W, muscle 1                                            20364       2.02       0.001731
  NM_008509                                                   Lpl lipoprotein lipase                                                16956       −3.3       0.000892
  BC010197                                                    Cpe carboxypeptidase E                                                12876       −2.11      0.000013
  AF145253                                        Sec61a1 Sec61 alpha 1 subunit (S. cerevisiae)                                     53421       −2.13      0.005158
  NM_007823                                Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1                             13120       −1.92      0.00051
  BC013477                                            Adh1 alcohol dehydrogenase 1 (class I)                                        11522       −1.92      0.007629
  NM_013560                                                 Hspb1 heat shock protein 1                                              15507       −2.56      0.004221
  NM_013475                                                   Apoh apolipoprotein H                                                 11818       −2.66      0.003569
  BC021352                                   Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2                               26432       −1.98      0.012487
  NM_029550                                                Keg1 kidney expressed gene 1                                             64697       −1.85      0.000586
  NM_008766                           Slc22a6 solute carrier family 22 (organic anion transporter), member 6                        18399       −1.8       0.001602
  NM_007376                                                 Pzp pregnancy zone protein                                              11287       −2.24      0.022851
  NM_008878                            Serpinf2 serine (or cysteine) peptidase inhibitor, clade F, member 2                         18816       −2.54      0.001222
  NM_010007                                Cyp2j5 cytochrome P450, family 2, subfamily j, polypeptide 5                             13109       −2.12      0.042784
  NM_011435                                         Sod3 superoxide dismutase 3, extracellular                                      20657        −2        0.023677
  NM_021788                                             Sap30 sin3 associated polypeptide                                           60406       −1.82      0.005361
  NM_013478                                             Azgp1 alpha-2-glycoprotein 1, zinc                                          12007       −2.14      0.004734
  AW105741                        Slc16a2 solute carrier family 16 (monocarboxylic acid transporters), member 2                     20502       −2.32      0.007439
  BC012637                                             Aadat aminoadipate aminotransferase                                          23923       −1.97      0.007973
  NM_008129                                      Gclm glutamate-cysteine ligase, modifier subunit                                   14630       −2.06      0.015486
  BC016885                                              Ugt8a UDP galactosyltransferase 8A                                          22239       −2.77      0.004372
  L27424                                          Timp3 tissue inhibitor of metalloproteinase 3                                     21859       −2.34      0.006506
  NM_027884                                                       Tns1 tensin 1                                                     21961       −2.12      0.049487
  NM_013797                            Slco1a1 solute carrier organic anion transporter family, member 1a1                          28248      −11.51      0.014794
  NM_008079                                                 Galc galactosylceramidase                                               14420       −2.1       0.017597
  NM_030721                                        Acox3 acyl-Coenzyme A oxidase 3, pristanoyl                                      80911       −2.68      0.006701
  NM_007825                                Cyp7b1 cytochrome P450, family 7, subfamily b, polypeptide 1                             13123       −5.04      0.009947
  NM_015804                                             Atp11a ATPase, class VI, type 11A                                           50770       −2.76      0.012782
  BC020534                                               Cckar cholecystokinin A receptor                                           12425       −2.11      0.006061
  AB008174                                                    Hnf1b HNF1 homeobox B                                                 21410       −1.94      0.032091
  NM_008016                           Mpp6 membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)                         56524       −2.17      0.00856
  NM_053097                                                    Cml3 camello-like 3                                                  93674       −2.48      0.001103
  NM_010232                                           Fmo5 flavin containing monooxygenase 5                                        14263       −2.66      0.000267
  NM_008173                                   Nr3c1 nuclear receptor subfamily 3, group C, member 1                                 14815       −1.86      0.006131
  NM_008261                                           Hnf4a hepatic nuclear factor 4, alpha                                         15378       −2.08      0.004817
  NM_010517                                    Igfbp4 insulin-like growth factor binding protein 4                                  16010       −2.37      0.00307
  NM_010496                                               Id2 inhibitor of DNA binding 2                                            15902       −1.88      0.004033
  NM_009203                      Slc22a12 solute carrier family 22 (organic anion/cation transporter), member 12                    20521       −2.13      0.044714
  AK004192                                                      Cd36 CD36 antigen                                                   12491       −2.07      0.000977
  NM_001160404              Galnt1 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1               14423       −2.22      0.001029
  NM_009467                                Ugt2b5 UDP glucuronosyltransferase 2 family, polypeptide B5                              22238       −1.99      0.005327
  NM_010279                         Gfra1 glial cell line derived neurotrophic factor family receptor alpha 1                       14585       −1.86      0.029282
  BC003451                                        Mat2a methionine adenosyltransferase II, alpha                                   232087       −2.03      0.000527
  BC019374                                      Gclc glutamate-cysteine ligase, catalytic subunit                                   14629       −2.18      0.00284
  BC025936                               Cyp4a12a cytochrome P450, family 4, subfamily a, polypeptide 12a                          277753       −3.57      0.000548
  U68542                                                     Cux1 cut-like homeobox 1                                               13047       −2.1       0.024224
  BC013521                                                      Anxa13 annexin A13                                                  69787       −1.94      0.041203
  AY038079                                           Fbxw11 F-box and WD-40 domain protein 11                                      103583       −2.24      0.009461
  BC003476          Cd74 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)      16149       −1.9       0.012558
  AB022340                                    Acsm3 acyl-CoA synthetase medium-chain family member 3                                20216       −3.76      0.001304
  AF213670                                                    Mlx MAX-like protein X                                                21428       −2.08      0.007919
  NM_001164099                                                Add3 adducin 3 (gamma)                                                27360       −1.84      0.002187
  BC027063                                         Bdh1 3-hydroxybutyrate dehydrogenase, type 1                                     71911       −2.16      0.001797
  BC023060                    Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1                216616       −2.16      0.001651
  S64539                                            Odc1 ornithine decarboxylase, structural 1                                      18263       −2.3       0.033305
  NM_009202                          Slc22a1 solute carrier family 22 (organic cation transporter), member 1                        20517       −1.95      0.002763
  AK003232                                                  Cbr3 carbonyl reductase 3                                              109857       −3.48      0.045187
  AK009736                                    Gpr137b-ps G protein-coupled receptor 137B, pseudogene                               664862       −2.01      0.00129
  AK006387                                       Me1 malic enzyme 1, NADP(+)-dependent, cytosolic                                   17436       −2.8       0.011484
  AK005023                                      Sel1l sel-1 suppressor of lin-12-like (C. elegans)                                  20338       −2.25      0.003066
  NM_001159375                                 Eif4a1 eukaryotic translation initiation factor 4A1                                  13681       −2.08      0.023416
  AK002362                                                       Myo5a myosin VA                                                    17918       −2.24      0.00322
  AK003786                                        Nfs1 nitrogen fixation gene 1 (S. cerevisiae)                                     18041       −2.05      0.009065
  AK007618                                                    Ak3 adenylate kinase 3                                                56248       −2.05      0.039247
  NM_008303                                          Hspd1 heat shock protein 1 (chaperonin)                                        15528       −2.75      0.037992
  NM_011631                                   Hsp90b1 heat shock protein 90, beta (Grp94), member 1                                 22027       −2.07      0.012751
  NM_010516                                               Cyr61 cysteine rich protein 61                                            16007       −2.08      0.007693
  NM_013614                                         Odc1 ornithine decarboxylase, structural 1                                      18263       −1.91      0.002118
  NM_001111289                                       Caprin1 cell cycle associated protein 1                                        53872       −1.93      0.041035
  NM_023908                            Slco3a1 solute carrier organic anion transporter family, member 3a1                         108116       −2.27      0.010399
  NM_019699                                               Fads2 fatty acid desaturase 2                                             56473       −2.1       0.011032
  AB046929                                 Chst7 carbohydrate (N-acetylglucosamino) sulfotransferase 7                              60322       −2.15      0.000153
  NM_033564                                     Mpv17l Mpv17 transgene, kidney disease mutant-like                                  93734       −2.04      0.004172
  AK003671                                                  Car3 carbonic anhydrase 3                                               12350       −2.4       0.020089
  NM_032000                                       Trps1 trichorhinophalangeal syndrome I (human)                                    83925       −1.83      0.008962
  AB031813                             Slco1a1 solute carrier organic anion transporter family, member 1a1                          28248       −5.5       0.024812
  NM_019657                                     Hsd17b12 hydroxysteroid (17-beta) dehydrogenase 12                                  56348       −1.91      0.02581
  NM_010302                                     Gna12 guanine nucleotide binding protein, alpha 12                                  14673       −1.82      0.010264
  NM_010232                                           Fmo5 flavin containing monooxygenase 5                                        14263       −3.12      0.000843
  AF319542                                        Kcnk5 potassium channel, subfamily K, member 5                                    16529       −2.11      0.038642
  NM_001159555                                                  Cd36 CD36 antigen                                                   12491       −3.35      0.002187
  NM_025903                                     Ifrd2 interferon-related developmental regulator 2                                  15983       −2.47      0.005388
  AF133669                                 Arl6ip1 ADP-ribosylation factor-like 6 interacting protein 1                             54208       −1.94      0.00508
  BC022130                               Slc26a1 solute carrier family 26 (sulfate transporter), member 1                          231583       −1.85      0.008221
  BC026422                                            Tgm1 transglutaminase 1, K polypeptide                                        21816       −2.49      0.000038
  BC026598                            Slc22a7 solute carrier family 22 (organic anion transporter), member 7                       108114       −7.3       0.004741
  M33324                                                   Ghr growth hormone receptor                                              14600       −2.58      0.005396
  M55333                                  Ace angiotensin I converting enzyme (peptidyl-dipeptidase A) 1                            11421       −2.45      0.006298
  NM_013876                                                Rnf11 ring finger protein 11                                             29864       −2.38      0.008352
  NM_001122683                                     Bdh1 3-hydroxybutyrate dehydrogenase, type 1                                     71911       −1.88      0.001252
  NM_009199       Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1    20510       −2.07      0.004881

Urinary Albumin Excretion Rate {#s2g}
------------------------------

The urinary albumin excretion rate was measured with a murine microalbuminuria ELISA kit (Exocell Inc., PA) according to the manufacturer's suggestions.

![Biological processes depicting genes that are altered in response to diabetes in wild type control mice and in B~2~R^−/−^ null mice are shown in pie chart.\
Data compares genes altered in B~2~R^−/−^D vs. B~2~R^+/+^D (**A**) upregulated genes and (**B**) downregulated genes.](pone.0044714.g007){#pone-0044714-g007}
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###### Upregulated and Downregulated Genes in B~2~R^−/−^D vs. B~2~R^+/+^D.

![](pone.0044714.t004){#pone-0044714-t004-4}

  Accession ID                                                         Gene                                                        Gene ID   Fold Change   P value
  -------------- ---------------------------------------------------------------------------------------------------------------- --------- ------------- ----------
  BC009155                                         Mgst1 microsomal glutathione S-transferase 1                                     56615       2.01       0.025734
  NM_019423                   Elovl2 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2                 54326       2.08       0.003068
  NM_021450                          Trpm7 transient receptor potential cation channel, subfamily M, member 7                       58800       1.83       0.002536
  BC027434                                          Hbb-b2 hemoglobin, beta adult minor chain                                       15130       2.41       0.026002
  NM_008218                                           Hba-a1 hemoglobin alpha, adult chain 1                                        15122       2.73       0.027316
  AF047838                                          Clca1 chloride channel calcium activated 1                                      12722       2.15       0.00938
  D89669                                  Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1                            13081       6.34       0.054554
  NM_008341                                    Igfbp1 insulin-like growth factor binding protein 1                                  16006       3.65       0.030456
  NM_027884                                                       Tns1 tensin 1                                                     21961       1.77       0.007886
  AAD38411                                       March7 membrane-associated ring finger (C3HC4) 7                                   57438       1.82       0.005006
  NM_008182                                       Gsta2 glutathione S-transferase, alpha 2 (Yc2)                                    14858       2.05       0.020506
  NM_011313                                     S100a6 S100 calcium binding protein A6 (calcyclin)                                  20200       2.51       0.003671
  NM_011169                                                  Prlr prolactin receptor                                                19116        2.6       0.018234
  NM_010145                                           Ephx1 epoxide hydrolase 1, microsomal                                         13849       2.32       0.015186
  NM_010424                                                    Hfe hemochromatosis                                                  15216       1.85       0.005272
  NM_001172121                             Rbms3 RNA binding motif, single stranded interacting protein                            207181       2.35       0.034332
  NM_010279                         Gfra1 glial cell line derived neurotrophic factor family receptor alpha 1                       14585       1.81       0.020694
  BC013343                                         Hpd 4-hydroxyphenylpyruvic acid dioxygenase                                      15445       1.97       0.007464
  NM_008096                                                Gc group specific component                                              14473       3.77       0.008264
  BC023060                    Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1                216616       2.13       0.001006
  AK009020                                            Clic3 chloride intracellular channel 3                                        69454       2.05       0.005867
  NM_145942                                  Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1                               208715       2.75       0.005719
  NM_019989                                 Sh3bgrl SH3-binding domain glutamic acid-rich protein like                              56726       2.04       0.037097
  NM_010169                                       F2r coagulation factor II (thrombin) receptor                                     14062       2.31       0.015754
  NM_007569                                    Btg1 B-cell translocation gene 1, anti-proliferative                                 12226       2.03       0.025775
  NM_001004148                  Slc13a5 solute carrier family 13 (sodium-dependent citrate transporter), member 5                  237831       1.86       0.029255
  NM_145569                                       Mat2a methionine adenosyltransferase II, alpha                                   232087        1.8       0.034233
  NM_001110831                                            Dnpep aspartyl aminopeptidase                                             13437        1.9       0.001443
  NM_009837                                     Cct4 chaperonin containing Tcp1, subunit 4 (delta)                                  12464       2.06       0.000479
  NM_009242                                      Sparc secreted acidic cysteine rich glycoprotein                                   20692        1.8       0.020269
  NM_008597                                                   Mgp matrix Gla protein                                                17313       1.91       0.002312
  NM_019975                                              Hacl1 2-hydroxyacyl-CoA lyase 1                                            56794       2.17       0.003102
  NM_054102                                       Ivns1abp influenza virus NS1A binding protein                                    117198        2.1       0.01779
  NM_013806                               Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2                             12780       2.18       0.019342
  NM_031166                                               Id4 inhibitor of DNA binding 4                                            15904       2.36       0.013276
  BC012874                           Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B                        20701       1.89       0.044292
  NM_029023                                              Scpep1 serine carboxypeptidase 1                                           74617       1.84       0.001437
  NM_009009                                               Rad21 RAD21 homolog (S. pombe)                                            19357       2.09       0.001454
  NM_010362                                          Gsto1 glutathione S-transferase omega 1                                        14873       2.43       0.008124
  NM_016792                                                  Txnl1 thioredoxin-like 1                                               53382       1.84       0.016406
  NM_011701                                                        Vim vimentin                                                     22352       1.95       0.026022
  NM_007620                                                 Cbr1 carbonyl reductase 1                                               12408        2.2       0.012532
  AF108501                                          Clca2 chloride channel calcium activated 2                                      80797       2.57       0.003658
  AF145253                                        Sec61a1 Sec61 alpha 1 subunit (S. cerevisiae)                                     53421       −2.11      0.005453
  NM_013560                                                 Hspb1 heat shock protein 1                                              15507       −2.36      0.004073
  BC021352                                   Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2                               26432        −2        0.005958
  NM_029550                                       Keg1 kidney expressed gene 1 \[Mus musculus \]                                    64697       −1.8       0.031526
  AK146840                                          Amd1 S-adenosylmethionine decarboxylase 1                                       11702        −2        0.014904
  NM_030706                                            Trim2 tripartite motif-containing 2                                          80890        −2        0.048874
  NM_010274                                   Gpd2 glycerol phosphate dehydrogenase 2, mitochondrial                                14571       −1.9       0.008751
  NM_008878                            Serpinf2 serine (or cysteine) peptidase inhibitor, clade F, member 2                         18816       −1.8       0.027152
  NM_011435                                         Sod3 superoxide dismutase 3, extracellular                                      20657        −2        0.00248
  BC006716                                                    Vdr vitamin D receptor                                                22337       −1.8       0.005698
  NM_019444                                  Ramp2 receptor (calcitonin) activity modifying protein 2                               54409       −3.2       0.027003
  AF067806                                                  Pde8a phosphodiesterase 8A                                              18584       −1.9       0.036591
  AF012834                              Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1                          56379       −2.1       0.025618
  NM_007788                                        Csnk2a1 casein kinase 2, alpha 1 polypeptide                                     12995        −2        0.033254
  L27424                                          Timp3 tissue inhibitor of metalloproteinase 3                                     21859       −2.1        0.0122
  NM_008079                                                 Galc galactosylceramidase                                               14420       −1.9       0.045887
  NM_023646                                     Dnaja3 DnaJ (Hsp40) homolog, subfamily A, member 3                                  83945       −1.9       0.007017
  NM_030721                                        Acox3 acyl-Coenzyme A oxidase 3, pristanoyl                                      80911        −2        0.018101
  NM_018760                                 Slc4a4 solute carrier family 4 (anion exchanger), member 4                              54403       −2.1       0.029658
  NM_001164733                        Mpp6 membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)                         56524       −2.1       0.023307
  NM_010890                   Mus musculus neural precursor cell expressed, developmentally down-regulated 4 (Nedd4)                17999       −1.9       0.000172
  NM_010517                                    Igfbp4 insulin-like growth factor binding protein 4                                  16010       −2.2       0.018949
  NM_008397                                                   Itga6 integrin alpha 6                                                16403       −2.3       0.03713
  NM_009203                      Slc22a12 solute carrier family 22 (organic anion/cation transporter), member 12                    20521       −1.9       0.010432
  NM_018881                                           Fmo2 flavin containing monooxygenase 2                                        55990       −1.9       0.000286
  NM_011851                                                 Nt5e 5′ nucleotidase, ecto                                              23959        −2        0.020878
  NM_001160404              Galnt1 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1               14423        −2        0.046958
  NM_009443                                             Tgoln1 trans-golgi network protein                                          22134       −2.2       0.006538
  BC019374                                      Gclc glutamate-cysteine ligase, catalytic subunit                                   14629       −1.8       0.014479
  BC025936                               Cyp4a12a cytochrome P450, family 4, subfamily a, polypeptide 12a                          277753       −2.2       0.050246
  BC021452                                        Ddx6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6                                     13209       −1.8       0.002793
  AY038079                                           Fbxw11 F-box and WD-40 domain protein 11                                      103583       −2.3       0.013332
  NM_016870                                   Acsm3 acyl-CoA synthetase medium-chain family member 3                                20216       −2.7       0.073051
  AF213670                                                    Mlx MAX-like protein X                                                21428       −1.8       0.025547
  NM_001164099                                                Add3 adducin 3 (gamma)                                                27360       −1.8       0.003839
  NM_001167745                                      Wasl Wiskott-Aldrich syndrome-like (human)                                      73178       −2.3       0.005224
  BC027063                                         Bdh1 3-hydroxybutyrate dehydrogenase, type 1                                     71911       −2.7        0.0021
  AK003232                                                  Cbr3 carbonyl reductase 3                                              109857       −2.57      0.049803
  AK014338                                   Manf mesencephalic astrocyte-derived neurotrophic factor                               74840       −1.9       0.027373
  NM_001159375                                 Eif4a1 eukaryotic translation initiation factor 4A1                                  13681       −2.2       0.006428
  NM_010911                                       Nfs1 nitrogen fixation gene 1 (S. cerevisiae)                                     18041       −2.1       0.002002
  AK015410                                                        Dnm2 dynamin 2                                                    13430       −2.1       0.004377
  AK013376                                       Aplp2 amyloid beta (A4) precursor-like protein 2                                   11804       −2.3       0.007349
  AK007618                                                    Ak3 adenylate kinase 3                                                56248       −2.2       0.026914
  NM_031843                                                 Dpp7 dipeptidylpeptidase 7                                              83768       −1.8       0.017748
  EDL19081                                                       Actb actin, beta                                                   11461       −1.88      0.006181
  NM_010477                                          Hspd1 heat shock protein 1 (chaperonin)                                        15510       −2.72      0.029635
  NM_011631                                   Hsp90b1 heat shock protein 90, beta (Grp94), member 1                                 22027       −2.17      0.009681
  NM_001111289                                       Caprin1 cell cycle associated protein 1                                        53872       −1.88      0.005003
  NM_080555                                        Ppap2b phosphatidic acid phosphatase type 2B                                     67916       −2.08      0.001515
  NM_011390                                         Slc12a7 solute carrier family 12, member 7                                      20499       −1.88      0.010937
  NM_010302                                     Gna12 guanine nucleotide binding protein, alpha 12                                  14673       −1.83      0.001605
  NM_019664                            Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15                         16516       −2.17      0.012327
  U41465                                                 Bcl6 B-cell leukemia/lymphoma 6                                            12053       −1.82      0.009357
  AF319542                                        Kcnk5 potassium channel, subfamily K, member 5                                    16529       −2.05      0.003671
  NM_008261                                           Hnf4a hepatic nuclear factor 4, alpha                                         15378       −1.8       0.00581
  NM_001159555                                                  Cd36 CD36 antigen                                                   12491       −2.58      0.021768
  NM_016697                                                      Gpc3 glypican 3                                                    14734       −2.43      0.001794
  BB540964                                      Ifrd2 interferon-related developmental regulator 2                                  15983       −2.09      0.036417
  BC022130                               Slc26a1 solute carrier family 26 (sulfate transporter), member 1                          231583       −1.81      0.011694
  M33324                                                   Ghr growth hormone receptor                                              14600       −2.71      0.020174
  NM_013876                                                Rnf11 ring finger protein 11                                             29864       −2.37      0.002724
  NM_026147                                                Rps20 ribosomal protein S20                                              67427       −1.97      0.023604
  NM_008538                                Marcks myristoylated alanine rich protein kinase C substrate                             17118       −1.96      0.011844
  NM_009199       Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1    20510       −2.21      0.008478
  U13836                                    Atp6v0a1 ATPase, H+ transporting, lysosomal V0 subunit A1                               11975       −1.9       0.007939

Systems Biology Analysis {#s2h}
------------------------

The microarray differential expression of the wild type B~2~R vs. knockout (B~2~R^−/−^) in control and diabetic phenotypes was further analyzed using a systems biology approach to assess the altered pathway(s) relevant to differential B~2~R knockout (B~2~R^−/−^) phenotype mice and its contribution to the development of Diabetes. PathwayStudio software (v 9.0; Ariadne Genomics, Rockville, MD, USA) was applied for the systems biology analysis. This software helps to interpret biological meaning from differential gene expression, build and analyze pathways, and identify altered cellular processes and molecular functions involved. PathwayStudio comes with a built-in resource named ResNet, which is a database of molecular interactions based on natural language processing of scientific abstracts in PubMed.

![Renal expression of (A) Superoxide dismutase 3, extracellular (EC-SOD), (B) Glutathione S-transferase, (GST), (C) Flavin containing monooxygenase (FMO) and (D) Insulin-like growth factor binding protein (IGFBP-1) in B~2~R^+/+^D and B~2~R^−/−^D.\
Renal cortex mRNA levels were measured by real time PCR. Data presented in the bar graph demonstrates that disruption of B~2~R results in significant increases in anti-oxidant enzymes as well as IGFBP-1 (\*P\<0.05 B~2~R^−/−^D vs. B~2~R^+/+^D, n = 3).](pone.0044714.g008){#pone-0044714-g008}

For gene ontology analysis including differential molecular function and biological processes involved, PANTHER software (Protein ANalysis THrough Evolutionary Relationships; <http://www.pantherdb.org/genes/batchIdSearch.jsp>) was utilized to classify proteins into distinct categories of molecular functions and biological processes. Panther software uses published scientific experimental evidence and evolutionary relationships abstracted by curators with the goal of predicting function even in the absence of direct experimental evidence. Proteins are classified into families and subfamilies of shared function, which are then categorized using a highly controlled vocabulary (ontology terms) by biological process, molecular function and molecular pathway.

![Pathways influenced by the validated targeted genes.\
Targeted system biology analysis of the biological process and molecular function of the 4 validated genes (Superoxide dismutase 3, extracellular (EC-SOD), Glutathione S-transferase, alpha 2(Yc2) (GST-Yc2), Flavin containing monooxygenase 2 (FMO2), Insulin-like growth factor binding protein (IGFBP-1). Similar to the identified altered pathways, these 4 proteins are shown to be related to the identified molecular pathways (apoptosis, oxidative stress and inflammation).](pone.0044714.g009){#pone-0044714-g009}

Statistical Methods {#s3}
===================

Power Analysis {#s3a}
--------------

Sample size calculation for our study was determined by using the formula by Hedeker D et al, for longitudinal data [@pone.0044714-Hedeker1]. In this study we assumed 80% power, significance of 5%, repeated measure correlation of 0.5, 9 measurement time points, within subject variance of 4.2, and medium effect size of 0.3. This resulted in 2.3 mice per group, and accounting for possible attrition effect we inflated our sample size by 20% so the sample size in each group will be 2.76 mice.

![Molecular & Biological Pathway Interaction Map Analysis upon Diabetes induction with or without disruption of B~2~R.\
Using Pathway Studio 9.0, altered genes relevant to diabetic induction with or without disruption of B~2~R. were analyzed. In B~2~R^−/−^D vs. B~2~R^+/+^D mice, a total of 109 genes were found to be altered (43 upregulated and 66 downregulated). The network was generated using "direct interaction" algorithm to map cellular processes and interactions among altered genes. Of interest, global Pathway analysis revealed association of these genes to oxidative stress mechanisms (ROS generation & oxidative stress), cardiac injury mechanisms along with pronounced inflammatory process with a marked alteration in the pro-apoptotic genes. The upregulated genes are shown in green and downregulated genes are in red.](pone.0044714.g010){#pone-0044714-g010}

Statistical Analysis {#s3b}
--------------------

Results are expressed as mean ± standard error, unless stated otherwise. All data were analyzed using SAS (SAS Institute Inc., Version 8, Cary, NC). t-tests were used to analyze continuous outcomes versus each covariate separately. To compare means values across three or more groups, ANOVA was used. Generalized linear models and generalized estimating equations were used to compare albumin excretion rates, plasma glucose levels and body weights within mice and across groups over time. A longitudinal data analysis was conducted to assess the effect of group on the AER levels over time. A mixed model was fit and spatial data covariance structure was used to accommodate for the unequally- spaced measurement time points. In this context, a continuous-time model was employed using variance-covariance matrix with type = sp (pow) in SAS PROC MIXED. Bonferroni correction was used to adjust for inflated type I error when making multiple comparisons. Statistical significance was determined using a two-sided test and significance was assumed for P-values ≤0.05.

Results {#s4}
=======

Characteristics of the Diabetic State {#s4a}
-------------------------------------

Plasma glucose levels were markedly elevated 2 weeks after STZ injection in both B~2~R^+/+^D and B~2~R^−/−^D groups of mice compared to their non-diabetic controls, and remained elevated throughout the study period ([Figure 1A](#pone-0044714-g001){ref-type="fig"}). On average plasma glucose levels increased by 205 mg/dl in B~2~R^−/−^D null mice and by 251 mg/dl in B~2~R^+/+^D null mice compared to B~2~R^+/+^C mice, P\<0.001. No significant difference in plasma glucose levels was observed between B~2~R^+/+^C mice and B~2~R^−/−^C mice, P = 0.276. No significant time effect on plasma glucose level was observed, P = 0.2647. Also no significant effect of group by time interaction on plasma glucose levels was detected, P = 0.28. Hence, the observed difference in plasma glucose levels across groups was primarily due to group effect.

Initial body weights were not significantly different between diabetic and non-diabetic mice. However, B~2~R^−/−^D mice had significantly reduced bodyweight after 14 weeks and B~2~R^+/+^D after 20 weeks compared with B~2~R^+/+^ C and B~2~R^−/−^ C mice and this reduction in body weight was maintained for the duration of the study ([Figure 1B](#pone-0044714-g001){ref-type="fig"}). Body weight analyses revealed that there was no significant group effect on bodyweights over time, but there was a significant effect of time on bodyweights, P = 0.0011. In addition, there was interaction between time and group effect on changes in body weights P = 0.0011. Thus, the decrease in bodyweights in B~2~R^−/−^D null mice and B~2~R^+/+^D mice compared to B~2~R^+/+^C mice are a result of time effect.

Albumin Excretion Rate {#s4b}
----------------------

The albumin excretion rate results are presented in [Figure 2](#pone-0044714-g002){ref-type="fig"}. Groups were defined as B~2~R^+/+^C, B~2~R^+/+^D, B~2~R^−/−^C and B~2~R^−/−^D. AER was modeled with a time and group main effect and a time by group effect. Since AER in each mouse was measured up to 10 times over 23 weeks, a longitudinal data analysis was conducted to assess the effect of group on the AER levels over time. A mixed model was fit and spatial data covariance structure was used to accommodate for the unequally-spaced measurement time points. Our results showed that there was a significant overall group effect with P\<0.0001. In particular, when the wild type control group B~2~R^+/+^C was considered as the reference group, we observed that B~2~R^−/−^D had a significant increase in the AER by 13.5 mg/24 h, P = 0.001. Overall, a significant increase by about 28.5 mg/24 h in AER was also observed for B~2~R^+/+^D mice compared to B~2~R^+/+^C mice P\<.0001. No significant differences in AER was observed between B2R^+/+^C and B2R^−/−^C, P = 0.1629.

Our result also showed that the B~2~R^−/−^D null mice had a significant decrease of 14.97 mg/24 h in the AER levels compared to wild type B~2~R^+/+^D mice, P = 0.0005. Some minor time effect on the AER was also observed. In particular, we can estimate that overall the AER appeared to be decreasing with time at a slow rate of 0.547 mg/24 h, P\<.0001. An interaction test was then performed which showed that there is no significant interaction between time and group (P-value  = 0.24). Although there was some minor effect of time on AER, the observed changes in AER across groups was mainly due to group effect rather than an effect of time.

Hierarchical Clustering of Gene Expression {#s4c}
------------------------------------------

Differential gene expression profiles in the kidney were identified among four groups of mice: B~2~R^+/+^C, B~2~R^+/+^D, B~2~R^−/−^C and B~2~R^−/−^D. Each column represents one sample, and the color bars represent the median value of three array experiments for an individual mouse for that gene ([Figure 3](#pone-0044714-g003){ref-type="fig"}).

Gene Regulation in Response to Disruption of B~2~R {#s4d}
--------------------------------------------------

Upon deletion of B~2~R, There were a total of 14 altered genes (4 upregulated and 9 downregulated shown in [**Table 1**](#pone-0044714-t001){ref-type="table"}); these include genes that code for ATPase activity, hemoglobin and enzymes involved in protein metabolism. Among the altered genes, Monoglyceride lipase (MGLL; EC 3.1.1.23) and lysine (K)-specific demethylase 2B (KDM2B) were found to be downregulated due to B~2~R deletion. KDM2B gene encodes a member of the F-box protein family lysine (K)-specific demethylase 2B which function in phosphorylation-dependent ubiquitination while MGLL gene functions together with hormone-sensitive lipase to hydrolyze intracellular triglyceride stores in adipocytes and other cells to fatty acids and glycerol. The biological processes depicting genes that are altered in response to B~2~R disruption are shown in [**Figures 4**](#pone-0044714-g004){ref-type="fig"} **A** and **B.**

Gene Regulation in Response to Diabetes {#s4e}
---------------------------------------

Upon Diabetes induction, a total of 9 genes were found to be upregulated and 16 genes downregulated compared to B~2~R^+/+^C wild type mice. An enriched pathways analysis identified genes associated with potassium transport, cell cycles and lipid metabolism as shown in [**Table 2**](#pone-0044714-t002){ref-type="table"}). The biological processes depicting genes that are altered in response to diabetes are shown in [**Figures 5A and B**](#pone-0044714-g005){ref-type="fig"} **.**

Of great interest, in B~2~R^−/−^ null mice, a total of 181 genes were regulated by diabetes including 91 upregulated genes and 90 downregulated genes, respectively ([**Table 3**](#pone-0044714-t003){ref-type="table"}). A thorough systems biology analysis of specific enriched pathways, several genes were found to be associated with: endothelial cellular injury, insulin & lipid metabolism, oxidative stress, cardiac and kidney toxicity as illustrated in the biological processes ([**Figures 6A & B**](#pone-0044714-g006){ref-type="fig"}).

Gene Expression in Diabetes with or without Disruption of B~2~R {#s4f}
---------------------------------------------------------------

In B~2~R^−/−^D vs. B~2~R^+/+^D mice, a total of 43 genes were upregulated and 66 genes were downregulated ([**Table 4**](#pone-0044714-t004){ref-type="table"}). Among these altered genes: IGFBP, GST, EC-SOD and GHR genes. In a detailed assessment of these genes, gene expressions of IGFBP-1(3.65 fold) and GST (Yc2, 2.05 fold; omega1, 2.43 fold) were elevated in the B~2~KR^−/−^D mice compared to the B~2~KR^+/+^D mice. On the other hand, gene expressions of Insulin-like growth factor-binding protein-4 (IGFBP-4) (−2.18 fold), EC-SOD (−1.95 fold), FMO2 (−1.94 Fold) and GHR (−2.7 fold) were suppressed in the B~2~KR^−/−^D mice compared to the B~2~KR^+/+^D mice, P\<0.05. The biological processes depicting genes that are altered in response to diabetes +/− B~2~R are shown in [Figure 7A & B](#pone-0044714-g007){ref-type="fig"}.

Validation of Specific Gene Expressions by Quantitative Real-time PCR Superoxide Dismutase 3, Extracellular (EC-SOD) {#s4g}
--------------------------------------------------------------------------------------------------------------------

EC-SOD gene encodes a member of the superoxide dismutase (SOD) protein family which are antioxidant enzymes that catalyze the dismutation of two superoxide radicals into hydrogen peroxide and oxygen protecting from oxidative stress. EC-SOD expression tended to be suppressed by diabetes in the wild type mice. Interestingly, in the B~2~R^−/−^D mice, EC-SOD expression was increased up to 37% compared to that in the B~2~R^+/+^D mice (\*P\<0.05 vs. B~2~R^+/+^D, [Figure **8A**](#pone-0044714-g008){ref-type="fig"}).

Glutathione S-transferase, Alpha 2(Yc2) (GST-Yc2) {#s4h}
-------------------------------------------------

GST-Yc2 catalyze the conjugation of reduced glutathiones and a variety of electrophiles, including many known carcinogens and mutagens. Our data indicated that the expression of GST was significantly higher in B~2~R^−/−^D mice compared to B~2~R^+/+^D mice (\*P\<0.05 vs. B~2~R^+/+^D, [Figure 8B](#pone-0044714-g008){ref-type="fig"}).

Flavin Containing Monooxygenase 2 (FMO2) {#s4i}
----------------------------------------

FMO2 family is NADPH-dependent enzymes that catalyze the oxidation of many drugs and xenobiotics. In the B~2~R^+/+^D mice, FMO2 expression was decreased up to 34% compared to that in the controls. However, the expression FMO2 was significantly higher in B~2~R^−/−^D mice compared with B~2~R^+/+^D mice (\*P\<0.05 vs. B~2~R^+/+^D, [Figure 8C](#pone-0044714-g008){ref-type="fig"}).

Insulin-like Growth Factor Binding Protein (IGFBP-1) {#s4j}
----------------------------------------------------

IGFBP-1 gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encoding proteins with an IGFBP domain and a thyroglobulin type-I domain. It binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma prolonging the half-life of the IGFs. In our work, the deletion of B~2~R didn't change the expression of IGFBP-1. However, IGFBP-1 expression was decreased up to 33% by diabetes in the wild type mice (P\<0.05). Interestingly, in B~2~R^−/−^D mice, IGFBP-1 expression was upregulated significantly: up to 2.7-fold increase compared to that in B~2~R^+/+^D (\*P\<0.05 vs. B~2~R^+/+^D, [Figure 8D](#pone-0044714-g008){ref-type="fig"}).

We next performed a targeted analysis to identify the involvement of these selected validated genes in the most highlighted altered pathways (apoptosis, oxidative stress and inflammation). These genes were shown to be highly related to the aforementioned pathways as shown in [**Figure 9**](#pone-0044714-g009){ref-type="fig"}.

Systems Biology Analysis of Altered Genes in B~2~R^−/−^D and B~2~R^+/+^D mice {#s4k}
-----------------------------------------------------------------------------

Pathway Studio 9.0 (2011, Ariadne Genomics, Rockville, MD) was also used to search for potential altered cellular processes, and related pathways for associations with gene alterations in our diabetic mice in the presence or absence of B~2~R. The network was generated using the "direct interaction" algorithm with the filters of "*Cellular process and Protein*" as Entity Type while the Relation Type parameter was set to "*Regulation Analysis*" to map altered pathways regulated by the identified (downregulation vs. upregulation) subsets of genes. Several processes believed to be central to the pathogenesis of DN included oxidative stress mechanisms (ROS generation & oxidative stress), cardiac injury mechanisms along with pronounced inflammatory process with a marked alteration in the pro-apoptotic genes as illustrated in [**Figure 10**](#pone-0044714-g010){ref-type="fig"} **.**

Discussion {#s5}
==========

A pivotal event initiated by DN is glomerular injury, characterized by mesangial deposition and podocyte loss. The degree of podocyte loss and mesangial expansion are strongly correlated with the clinical manifestations of DN, such as albuminuria and decreased GFR [@pone.0044714-Mauer1], [@pone.0044714-Drummond1], [@pone.0044714-StittCavanagh1]. Microalbuminuria, an early marker of DN, signifies high risk for progressive renal failure and cardiovascular disease [@pone.0044714-Brown1]. Microalbuminuria has also been associated with increased cardiovascular mortality in diabetic and non-diabetic populations and with generalized and glomerular endothelial dysfunction [@pone.0044714-Nakagawa1]. Identifying biomarkers and risk factors that contribute to the development of microalbuminuria may provide insights into the mechanisms of diabetic renal injury.

Few interventions have been shown to slow the progression of renal disease in diabetic patients. These include intensive glycemic control, blood pressure control and treatment with angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) [@pone.0044714-1], [@pone.0044714-Lewis1]. Despite these interventions and beneficial effects, diabetic patients progress with time to develop end stage renal disease. It is of significance to note here that a recent Interventional study aimed at blockade of the renin-angiotensin system (RAS) with ACE-inhibitors or ARBs, in patients with type 1 diabetes, did not slow nephropathy progression [@pone.0044714-Mauer2]. However, the exact factors responsible for these maladaptive signals leading to renal failure are poorly defined.

Metabolic imbalances associated with high tissue glucose and abnormal lipid levels in the diabetic state influence many pathways that contribute to the pathogenesis of DN [@pone.0044714-Busch1], [@pone.0044714-Rutledge1]. The modifiable factors engaged in these processes are yet to be identified but there is evidence for promotion of chronic low-grade inflammation, oxidative stress, endothelial dysfunction, stimulation of proliferative/apoptotic pathways, and deposition of extracellular matrix [@pone.0044714-Haneda1]--[@pone.0044714-Eid1]. Importantly, inflammatory mediators and growth factors are increasingly recognized as key players in the pathogenesis of DN [@pone.0044714-Ziyadeh1]--[@pone.0044714-RinconCholes1].

Our published work has provided evidence for the involvement of the kallikrein-kinin system (KKS) in the initiation of DN [@pone.0044714-Harvey1], [@pone.0044714-Tan2]. In the current work, we performed longitudinal data analysis to assess the rate of change in AER levels over time among the 4 different groups. Our data indicated that targeted deletion of B~2~R in mice interferes with the progression of DN. Diabetic B~2~R^−/−^ mice display reduced AER compared to diabetic B~2~R^+/+^ mice. Other investigators have also implicated a role for B~2~R in DN. Polymorphisms in the human B~2~R have been linked to increased albuminuria in diabetic patients and to the development of chronic renal failure [@pone.0044714-Maltais1], [@pone.0044714-Jozwiak1]. In addition, blockade of B~2~R markedly reduced the proteinuria in STZ-diabetic mice and inhibition of B~2~R ameliorated the accelerated nephropathy in uninephrectomized db/db mice, lending support to the pathogenic role of B~2~R in DN [@pone.0044714-Zuccollo1], [@pone.0044714-Tang1].

Contrary to the aforesaid findings, Kakoki and Smithies have reported a protective role for B~2~R in DN. They have shown that the insulin Akita (Ins2^Akita^) mice crossed with null B~2~R (In2^Akita^/B~2~R^−/−^) or with double-null B~2~R and B~1~R (In2^Akita^/B~2~R^−/−/^B~1~R^−/−^) displayed increased albuminuria compared to Ins2^Akita^ mice alone [@pone.0044714-Kakoki1], [@pone.0044714-Kakoki2].Other factors contributing to these apparent differences in the role of B~2~R in DN may be attributed to differences in the model of DN studied, genetic background of the animal models studied, severity and metabolic control of the diabetic state, specifics of the experimental design, the end points measured. It is noteworthy to point here that a confounding factor to be considered when using the Insulin Akita mouse is the propensity for these mice to develop mesangial deposits of IgG [@pone.0044714-Haseyama1].

To investigate the underlying mechanisms and involved pathways linking the role of B~2~R genotype to the development/progression of DN, we examined the contribution of B~2~R genotype on the global genomics level. We performed a global microarray study comparing gene expression profiles among four groups of mice respectively: (B~2~R^+/+^C, B~2~R^+/+^D, B~2~R^−/−^C and B~2~R^−/−^D). Findings from this work highlighted the role of several altered pathological pathways involved in the development of diabetes in the B~2~R^−/−^D vs. B~2~R^−/−^C mice which included: endothelial injury, oxidative stress, and insulin and lipid metabolism.

A detailed analysis of the top scoring biological processes data \[*Panther Analysi*s\] reflected the central role of B~2~R to increased immune response/inflammation along with other cellular functions (transport, systems process and response to stimulus which can be linked to protective/compensatory mechanism. This is in accordance with a previous study by Bascands et al, in which a global microarray renal gene expression changes were examined in lipopolysacharide-treated wild-type and kinin B~1~ receptor-knockout mice to investigate underlying mechanisms of renal inflammation reflected the role of acute phase response and inflammatory process [@pone.0044714-Bascands1].

This is in contrast to the sole effect of diabetes induction in wild type mice which reflected more pronounced metabolic/cellular processes changes (metabolites precursor generation, cellular adhesion, and cellular communication) rather than inflammatory immune response mediated response. Of interest, is the upregulation of one of the genes, aquaporin 4, (AQP4, 2.24) due to diabetes. AQP4 functions as a water transport channel in the kidney and has been shown to be downregulated in mice lacking B~2~R [@pone.0044714-Monti1].

These results validate existing published literature linking renal inflammation to early events of renal disease [@pone.0044714-Keepers1]--[@pone.0044714-Panzer1]. Furthermore, a global systems biology analysis among the diabetic mice with or without disruption of B~2~R **(**B~2~R^−/−^D vs. B~2~R^+/+^D) illustrated the role of oxidative stress mechanisms (ROS generation & oxidative stress), along with inflammatory process with a marked alteration in the pro-apoptotic genes. Indeed, these results may reflect a pathologic exacerbative role of B~2~R in inducing cellular vascular injury mediated via apoptotic pathways in the presence of diabetes. These findings are in concert with other microarray studies involving B~1~ and B~2~ receptor knockout mice [@pone.0044714-Schanstra1], [@pone.0044714-Bachvarov1].

Taken together, the finding of this study investigates the contributing role of B~2~-receptors in either exacerbating or at least enhancing the occurrence of diabetic nephropathy. In conclusion, the present study investigates the impact B~2~R deletion on the development of DN. A critical analysis of the data hints that renal function is preserved in the B~2~R^−/−^D mice especially at the early stages of DN, compared to that of B~2~R^+/+^D mice; these data were substantiated by the genomics/systems biology analysis. To the best of knowledge, this represents the first study that utilizes wide scale genomic/systems biology analysis in B~2~R^−/−^D mice. Finally, several of the identified genes (EC-sod, GST, IGFBP1 and FMO) were validated with RT-PCR to confirm gene alteration. Further studies including immunohistological analysis and assessment of protein levels and the activities of the antioxidants identified are certainly necessary to further evaluate the contributing role of the disruption of the B~2~-receptors.
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